Drug comparisons
Alogliptin vs Troglitazone
Alogliptin vs Troglitazone for type 2 diabetes: Alogliptin is a safer DPP-4 inhibitor, while Troglitazone was withdrawn for liver toxicity.
No comparison dimensions are available for this page.
Clinical context
Patients with type 2 diabetes seeking alternatives to older diabetes drugs may compare Alogliptin to Troglitazone.
Bottom line
Alogliptin is a safer and more effective choice than the discontinued Troglitazone for managing type 2 diabetes.
All medication comparisons